Caledonia to sell stake in Stonehage Fleming to Corient

Caledonia Investments plc has agreed to divest its minority stake in multi-family office Stonehage Fleming to US-based Corient Private Wealth LLC for approximately £288 million in net cash proceeds, representing a 3.2x multiple on its invested cost. The transaction, subject to regulatory approvals, is anticipated to close in the first half of 2026, with the majority of the proceeds paid upfront and an additional contingent payment possible. This strategic exit, following a six-year investment period during which Stonehage Fleming significantly expanded its market presence, will provide Caledonia with capital for future investment opportunities.

Analysis

Caledonia Investments plc (CLDN) has executed a strategic divestment of its minority stake in Stonehage Fleming, realizing a significant return and reinforcing the value of its private capital strategy. The sale to Corient Private Wealth LLC will generate net cash proceeds of approximately £288 million, representing a substantial 30% uplift over its £221 million carrying value as of March 31, 2025. This transaction crystallizes a 3.2 times multiple on Caledonia's initial invested cost, including dividends received since the investment began in July 2019. The proceeds will be received in stages, with £251 million upon closing in the first half of 2026, followed by two installments totaling £37 million within 12 months, and a potential £9 million contingent on future revenue growth. This successful exit not only validates Caledonia's ability to foster growth in its portfolio companies—as evidenced by Stonehage Fleming's expansion into the largest independent multi-family office in EMEA during the investment period—but also provides significant liquidity. The capital, to be held on deposit, bolsters Caledonia's 'dry powder' for future investment opportunities, positioning the trust for its next phase of capital allocation.

Key Decisions for Investors

• This successful exit at a significant premium to its carrying value validates the strength of Caledonia's private capital investment strategy and should be viewed as a positive catalyst for its Net Asset Value (NAV) upon completion.
• Investors should monitor management's future capital allocation plans, as the effective deployment of the £288 million in 'dry powder' will be critical for driving future shareholder returns.
• Note the transaction's timeline, with completion set for H1 2026 and full payment realization extending into 2027, which implies a delayed, rather than immediate, impact on liquidity and new investment capacity.